 BOSTON, May 24, 2021 GLOBE NEWSWIRE -- Ziopharm Oncology, Inc. Ziopharm or the Company Nasdaq: ZIOP, a clinical-stage cellular therapy company focused on hematologic and solid tumor cancers, today announced that Company management will participate in two upcoming investor conferences: 